Atlas Trials

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Clinical trial NCT07377838 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07377838
Sponsor
EHL Bio Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2026-06-01
Primary completion
2029-06-01
Enrollment
286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.